Carbohydrate restriction for diabetes: rediscovering age-old wisdom - A review of the evidence
The analyzed study proposes that reducing carbohydrates can decrease glycemia after meals, insulinemia, and cardiometabolic factors in type 2 diabetes. Independent evidence confirms benefits, especially in the short term. The possible functional relief of beta cells is plausible but still requires longer, controlled studies in humans.
- Published 11/11/2026
- Updated 11/11/2026
- Article history
ABSTRACT
The analyzed study is a synthesis contribution that re-examines the renewed interest in carbohydrate restriction for diabetes. The objective is to discuss whether a lower intake of carbohydrates can improve body weight, post-meal glycemia, insulinemia, and other cardiometabolic risk factors, especially in type 2 diabetes. The available material is the abstract only: it does not report an experimental sample, an intervention protocol, or new quantitative results produced directly by the authors.
In the narrative of "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi, the publication contributes to the passage stating that meal planning with a lower glycemic load can reduce glycemic variability, limit hyperinsulinemia, and lighten the workload required of pancreatic beta cells. Independent human studies confirm reductions in postprandial glycemia and some short-term improvements in glycemic control. However, the long-term persistent effects and the direct improvement of beta-cell function remain less certain and also depend on weight loss, dietary adherence, and the overall composition of the diet.
Analyzed study
Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom
DOI: 10.1172/jci142246
PMID: 33393511
PMCID: PMC7773350
The question addressed is whether carbohydrate restriction could once again become a useful nutritional strategy for people with diabetes, after having been historically used before the availability of insulin. The hypothesis discussed is straightforward: since carbohydrates are the main dietary source of glucose, reducing their intake could decrease the rise in glycemia after meals and, consequently, the need for insulin secretion or hypoglycemic therapy.
Its relevance to paragraph 2.3 is therefore specific. The publication was used to support the final segment of the narrative: lower carbohydrate exposure can help contain glycemic variability and hyperinsulinemia, that is, persistently high insulin levels. However, it does not directly demonstrate the entire chain described in the book, nor does it prove that every person achieves the same result, nor does it independently document a long-term clinical benefit.
Since the available material contains only the abstract, the study should be interpreted as a narrative perspective based on the literature and not as a new clinical trial. It can frame a biologically reasonable hypothesis, but it does not by itself provide a quantitative measure of the effect or original causal evidence.
Materials and methods of the original study
The abstract indicates that the authors discuss preliminary evidence regarding low carb diets in type 2 diabetes and, with more limited data, in type 1 diabetes. Potential areas of benefit mentioned include body weight, postprandial hyperglycemia—that is, the increase in glucose after a meal—hyperinsulinemia, and other cardiometabolic factors. This information does not equate to the description of a systematic review: the available material does not report a search strategy, study selection criteria, or risk of bias assessment.
Results
The analyzed study does not present its own experimental results with numerical values. The abstract states that reduced-carbohydrate diets have shown preliminary evidence of benefit for weight, postprandial hyperglycemia, hyperinsulinemia, and other cardiometabolic risk factors in type 2 diabetes. However, the authors emphasize that high-quality, long-term studies are needed to clarify safety and clinical efficacy.
The most conceptually relevant result for the book is the proposed direction of the effect: reducing carbohydrates can decrease glucose exposure after meals and may therefore reduce the immediate stimulus for insulin secretion. This relationship is consistent with physiology, but the abstract does not report data that would allow for quantifying the reduction, establishing the optimal carbohydrate threshold, or demonstrating a lasting relief of pancreatic beta-cell function.
Interpretation
In simple terms, if less absorbable glucose reaches a meal, the body has to manage a potentially lower glycemic load. This can attenuate the blood glucose spike and reduce, at least in some circumstances, the amount of insulin required to bring it back to normal levels. Pancreatic beta cells are the cells that produce insulin; speaking of "lightening the functional load" means hypothesizing that they have to respond to less extensive or less frequent glycemic stimuli.
The segment supported by the publication subject to the Evidence Review is therefore: lower dietary carbohydrate availability → lower postprandial hyperglycemia and lower potential insulin exposure. The next step, i.e., lower chronic functional stress on beta cells and better metabolic homeostasis in the long term, is a plausible pathophysiological interpretation but is not directly demonstrated by the available abstract.
It is also necessary to distinguish between lower insulinemia and better beta-cell function. A reduction in circulating insulin can result from a lower glucose stimulus, different insulin sensitivity, or both factors. It does not automatically prove that beta cells have been preserved or regenerated. For this reason, confirming the narrative requires studies that separately measure glycemia, insulin, beta-cell function, body weight, and duration of diet adherence.
Independent confirming evidence
Direct confirmation of the postprandial segment comes from a randomized crossover study involving 28 people with type 2 diabetes. After six weeks on a lower-carb, higher-protein diet compared to a conventional diabetes diet, the area under the curve for post-meal glycemia was reduced by 60%, and 24-hour glycemia by 13%. Estimated postprandial insulin secretion also decreased by 24%, while certain indices of beta-cell response to glucose improved. The crossover design allows for the comparison of the two dietary phases within the same individual; however, it remains a short-term study and does not completely separate the effect of carbohydrate reduction from that of increased protein and fat intake [1].
A systematic review and meta-analysis of 23 randomized studies, involving 1,357 participants with type 2 diabetes, reinforces the idea that low carb diets can improve certain outcomes in the short term. At six months, compared to control diets, the proportion of participants with glycated hemoglobin below 6.5% was higher: 57% versus 31%, with an absolute difference of 32%. Glycated hemoglobin indicates average glucose exposure over the previous two to three months. The authors noted, however, that the benefits regarding weight, triglycerides, and insulin sensitivity tended to diminish within twelve months and that long-term data were more uncertain [2].
A dose-response meta-analysis of randomized studies analyzed whether the magnitude of carbohydrate reduction was linked to metabolic changes in type 2 diabetes. The overall picture indicates a consistent relationship between greater carbohydrate restriction and reductions in glycated hemoglobin, fasting glycemia, triglycerides, and fasting insulin across many experimental comparisons. This evidence supports the transition of “lower glycemic load → lower glycemic and insulin exposure,” but it does not identify a single dietary composition valid for everyone, nor does it establish permanent clinical effects on its own [3].
Taken together, these independent studies primarily confirm the immediate direction of the book's narrative: in adults with type 2 diabetes, a reduction in carbohydrates can lower post-meal glycemia and certain indicators of insulin demand. The confirmation is less direct for the expression “lightening the load on beta cells,” because this concept requires specific measurements and results maintained over time.
Conflicting evidence
A six-week randomized trial showed that weight loss can be an important and independent determinant of metabolic improvement. Seventy-two adults with type 2 diabetes and obesity followed either a low carb, high-protein diet or a conventional diet, both designed to achieve approximately 6% weight loss. Both groups improved insulin sensitivity and beta-cell function indices, but the lower-carb diet did not improve these indices more than the conventional diet, despite better glycemic control. This result does not deny that reducing carbohydrates mitigates glycemia; however, it indicates that improvements in beta-cell function cannot be automatically attributed solely to carbohydrate restriction [4].
No further directly conflicting evidence of sufficient relevance was identified; this does not prove the absence of contrary results. Differences between studies depend on duration, the actual degree of carbohydrate reduction, the quality of fats and proteins, antidiabetic medications, weight loss, and adherence to the dietary plan. These elements limit the ability to extend a result to all people with diabetes.
Summary table of evidence
The table distinguishes the publication that is the subject of the review from the independent research used to verify the book's narrative passage.
| Reference | Study type | Population or model | Main result | Direction of evidence | Strength of evidence |
|---|---|---|---|---|---|
| Original study | Narrative perspective based on literature | Not applicable; only the abstract is available | Proposes preliminary benefits of carbohydrate restriction on postprandial glycemia, insulinemia, and cardiometabolic factors | biologically consistent evidence | preliminary |
| [1] | Crossover RCT | 28 adults with type 2 diabetes | The low carb diet reduced postprandial glycemic exposure by 60% and estimated postprandial insulin secretion by 24% | direct confirmation | moderate |
| [2] | Systematic review and meta-analysis of RCTs | 23 trials, 1,357 adults with type 2 diabetes | At six months, better glycemic control with low carb diets; benefits less clear at twelve months | indirect confirmation | moderate |
| [3] | Systematic review and dose-response meta-analysis of RCTs | 50 trials, 4,291 people with type 2 diabetes | A greater reduction in carbohydrates was associated with reductions in several glycemic and metabolic indicators | indirect confirmation | moderate |
| [4] | Parallel RCT | 72 adults with type 2 diabetes and obesity | With equal weight loss, the low carb diet did not improve beta-cell function more than the conventional diet | discordant evidence | moderate |
Confirmation of the evidence
Claim in the book
In section 2.3 of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi, the relevant statement is that proper meal planning can reduce glycemic variability, limit chronic hyperinsulinemia, and lighten the functional load placed on pancreatic beta cells, contributing to the maintenance of metabolic homeostasis.
Lower carbohydrate load → lower postprandial increase in glycemia → lower potential insulin demand → lower insulin exposure → possible functional relief of beta cells
The publication subject to the Evidence Review was used in the book to support the following passage: reducing carbohydrates in the diet can help decrease post-meal hyperglycemia and hyperinsulinemia, creating conditions potentially favorable to a lower functional demand on pancreatic beta cells.
The scientific correspondence exists because the analyzed study places carbohydrate restriction among the strategies capable of reducing postprandial hyperglycemia and hyperinsulinemia in type 2 diabetes. The independent crossover study by Skytte and colleagues directly documents the initial part of the chain: fewer carbohydrates, in the context of the experimental diet, reduced both post-meal glycemia and estimated postprandial insulin secretion [1].
Independent meta-analysis confirm that, in randomized trials, lower-carb diets can improve glycemic control, especially within six months, and that a greater degree of restriction is generally associated with improvements in glycemic indicators and fasting insulin [2,3]. Therefore, the part of the narrative regarding lower glycemic and insulin exposure is quite well supported.
“The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi extends this logic to the potential relief of beta cells. Caution is necessary here: the trial that controlled for weight loss did not find an additional advantage of carbohydrate restriction on beta-cell function indices compared to a conventional diet [4]. The most rigorous interpretation, therefore, is that carbohydrate restriction can reduce the immediate glycemic and insulin load, while the long-term preservation or improvement of beta cells is not unequivocally proven.
Overall level of confirmation
MODERATE CONFIRMATION
The relationship between lower carbohydrate intake, reduction in postprandial glycemia, and lower insulin demand is supported by randomized studies and meta-analysis. However, the transition toward a direct and persistent benefit for beta-cell function remains conditioned by the short duration of studies, weight loss, and the overall composition of the diets.
Conclusions
The publication subject to the Evidence Review is consistent with the book section because it highlights the potential of carbohydrate restriction in reducing postprandial glycemia and hyperinsulinemia in type 2 diabetes. Independent evidence moderately confirms this direction, especially in the short term. It is more prudent, however, to consider the alleged stable relief of beta cells as a physiologically plausible hypothesis that has not yet been uniformly demonstrated. The effects depend on weight loss, adherence, medications, and the overall quality of the diet.
Overall assessment
The narrative is moderately supported: reducing carbohydrates can lower postprandial glycemia and certain indicators of insulin demand in type 2 diabetes. The biological mechanism is consistent and documented in the short term. Lasting improvement in beta-cell function, however, remains less certain and requires longer-term confirmation.
References
[1] Effects of carbohydrate restriction on postprandial glucose metabolism, b-cell function, gut hormone secretion, and satiety in patients with Type 2 diabetes
[2] Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data
[3] Dose-dependent effect of carbohydrate restriction for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized controlled trials
[4] Weight loss improves b-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial
Editorial note
Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.
The manuscript was also subject to independent peer review prior to publication.
To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.